Rankings
▼
Calendar
SOPH
SOPHiA GENETICS S.A.
$308M
Q1 2024 Earnings
Healthcare
Medical - Healthcare Information Services
Income Statement
Revenue
$16M
+13.0% YoY
Gross Profit
$10M
65.9% margin
Operating Income
-$19M
-118.9% margin
Net Income
-$14M
-86.8% margin
EPS (Diluted)
$-0.21
QoQ Revenue Growth
-7.4%
Cash Flow
Operating Cash Flow
-$15M
Free Cash Flow
-$17M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$180M
Total Liabilities
$48M
Stockholders' Equity
$132M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$16M
$14M
+13.0%
Gross Profit
$10M
$10M
+7.3%
Operating Income
-$19M
-$19M
+2.8%
Net Income
-$14M
-$20M
+30.4%
← FY 2024
All Quarters
Q2 2024 →
SOPH Q1 2024 Earnings — SOPHiA GENETICS S.A. Revenue & Financial Results | Market Cap Arena